December 12, 2019
A Delaware federal judge won't give Orexo AB another chance to prove that a Teva unit's generic version of the opioid addiction treatment drug Suboxone infringes a patent covering its own drug Zubsolv.
March 29, 2019
A Teva Pharmaceuticals Ltd. subsidiary did not infringe Orexo AB's opioid addiction treatment drug Zubsolv with two generic drugs, a Delaware federal jury ruled Friday, after a five-day trial over Orexo's infringement case that sought at least $41 million in damages.